193 related articles for article (PubMed ID: 35763977)
21. Shared and Specific Patterns of Structural Brain Connectivity Across Affective and Psychotic Disorders.
Repple J; Gruber M; Mauritz M; de Lange SC; Winter NR; Opel N; Goltermann J; Meinert S; Grotegerd D; Leehr EJ; Enneking V; Borgers T; Klug M; Lemke H; Waltemate L; Thiel K; Winter A; Breuer F; Grumbach P; Hofmann H; Stein F; Brosch K; Ringwald KG; Pfarr J; Thomas-Odenthal F; Meller T; Jansen A; Nenadic I; Redlich R; Bauer J; Kircher T; Hahn T; van den Heuvel M; Dannlowski U
Biol Psychiatry; 2023 Jan; 93(2):178-186. PubMed ID: 36114041
[TBL] [Abstract][Full Text] [Related]
22. Transdiagnostic neurocognitive deficits in patients with type 2 diabetes mellitus, major depressive disorder, bipolar disorder, and schizophrenia: A 1-year follow-up study.
Correa-Ghisays P; Sánchez-Ortí JV; Balanzá-Martínez V; Selva-Vera G; Vila-Francés J; Magdalena-Benedito R; Victor VM; Escribano-López I; Hernández-Mijares A; Vivas-Lalinde J; San-Martín C; Crespo-Facorro B; Tabarés-Seisdedos R
J Affect Disord; 2022 Mar; 300():99-108. PubMed ID: 34965401
[TBL] [Abstract][Full Text] [Related]
23. Asymmetrical alterations of grey matter among psychiatric disorders: A systematic analysis by voxel-based activation likelihood estimation.
Huang K; Kang Y; Wu Z; Wang Y; Cai S; Huang L
Prog Neuropsychopharmacol Biol Psychiatry; 2021 Aug; 110():110322. PubMed ID: 33838150
[TBL] [Abstract][Full Text] [Related]
24. Transdiagnostic time-varying dysconnectivity across major psychiatric disorders.
Li C; Dong M; Womer FY; Han S; Yin Y; Jiang X; Wei Y; Duan J; Feng R; Zhang L; Zhang X; Wang F; Tang Y; Xu K
Hum Brain Mapp; 2021 Mar; 42(4):1182-1196. PubMed ID: 33210798
[TBL] [Abstract][Full Text] [Related]
25. Prescription of potentially inappropriate psychotropic drugs in homeless people with schizophrenia and bipolar disorders. Results from the French Housing First (FHF) program.
Fond G; Tinland A; Boucekine M; Girard V; Loubière S; Auquier P; Boyer L;
Prog Neuropsychopharmacol Biol Psychiatry; 2019 Mar; 89():84-89. PubMed ID: 30153497
[TBL] [Abstract][Full Text] [Related]
26. JAK-STAT and AKT pathway-coupled genes in erythroid progenitor cells through ontogeny.
Cokic VP; Bhattacharya B; Beleslin-Cokic BB; Noguchi CT; Puri RK; Schechter AN
J Transl Med; 2012 Jun; 10():116. PubMed ID: 22676255
[TBL] [Abstract][Full Text] [Related]
27. Network Pharmacology and Experimental Evidence: PI3K/AKT Signaling Pathway is Involved in the Antidepressive Roles of Chaihu Shugan San.
Zhang S; Lu Y; Chen W; Shi W; Zhao Q; Zhao J; Li L
Drug Des Devel Ther; 2021; 15():3425-3441. PubMed ID: 34385814
[TBL] [Abstract][Full Text] [Related]
28. Multivariate meta-analyses of mitochondrial complex I and IV in major depressive disorder, bipolar disorder, schizophrenia, Alzheimer disease, and Parkinson disease.
Holper L; Ben-Shachar D; Mann JJ
Neuropsychopharmacology; 2019 Apr; 44(5):837-849. PubMed ID: 29855563
[TBL] [Abstract][Full Text] [Related]
29. Platelet-derived growth factor BB: A potential diagnostic blood biomarker for differentiating bipolar disorder from major depressive disorder.
Idemoto K; Ishima T; Niitsu T; Hata T; Yoshida S; Hattori K; Horai T; Otsuka I; Yamamori H; Toda S; Kameno Y; Ota K; Oda Y; Kimura A; Hashimoto T; Mori N; Kikuchi M; Minabe Y; Hashimoto R; Hishimoto A; Nakagome K; Iyo M; Hashimoto K
J Psychiatr Res; 2021 Feb; 134():48-56. PubMed ID: 33360224
[TBL] [Abstract][Full Text] [Related]
30. TREM-1 and DAP12 expression in monocytes of patients with severe psychiatric disorders. EGR3, ATF3 and PU.1 as important transcription factors.
Weigelt K; Carvalho LA; Drexhage RC; Wijkhuijs A; de Wit H; van Beveren NJ; Birkenhäger TK; Bergink V; Drexhage HA
Brain Behav Immun; 2011 Aug; 25(6):1162-9. PubMed ID: 21421043
[TBL] [Abstract][Full Text] [Related]
31. Association of antipsychotic treatment switching in patients with schizophrenia, bipolar, and major depressive disorders.
Ayyagari R; Thomason D; Mu F; Philbin M; Carroll B
J Med Econ; 2020 Feb; 23(2):204-212. PubMed ID: 31663802
[No Abstract] [Full Text] [Related]
32. Genetic Liabilities Differentiating Bipolar Disorder, Schizophrenia, and Major Depressive Disorder, and Phenotypic Heterogeneity in Bipolar Disorder.
Richards AL; Cardno A; Harold G; Craddock NJ; Di Florio A; Jones L; Gordon-Smith K; Jones I; Sellers R; Walters JTR; Holmans PA; Owen MJ; O'Donovan MC
JAMA Psychiatry; 2022 Oct; 79(10):1032-1039. PubMed ID: 36044200
[TBL] [Abstract][Full Text] [Related]
33. Biological rhythms in bipolar and depressive disorders: A community study with drug-naïve young adults.
Duarte Faria A; Cardoso Tde A; Campos Mondin T; Souza LD; Magalhaes PV; Patrick Zeni C; Silva RA; Kapczinski F; Jansen K
J Affect Disord; 2015 Nov; 186():145-8. PubMed ID: 26241662
[TBL] [Abstract][Full Text] [Related]
34. The prevalence and illness characteristics of DSM-5-defined "mixed feature specifier" in adults with major depressive disorder and bipolar disorder: Results from the International Mood Disorders Collaborative Project.
McIntyre RS; Soczynska JK; Cha DS; Woldeyohannes HO; Dale RS; Alsuwaidan MT; Gallaugher LA; Mansur RB; Muzina DJ; Carvalho A; Kennedy SH
J Affect Disord; 2015 Feb; 172():259-64. PubMed ID: 25451425
[TBL] [Abstract][Full Text] [Related]
35. Acute anxiety disorder, major depressive disorder, bipolar disorder and schizophrenia are related to different patterns of nigrostriatal and mesolimbic dopamine dysfunction.
Nikolaus S; Mamlins E; Hautzel H; Müller HW
Rev Neurosci; 2019 May; 30(4):381-426. PubMed ID: 30269107
[TBL] [Abstract][Full Text] [Related]
36. Systematic Review and Meta-Analysis on MS-Based Proteomics Applied to Human Peripheral Fluids to Assess Potential Biomarkers of Bipolar Disorder.
Rodrigues JE; Martinho A; Santos V; Santa C; Madeira N; Martins MJ; Pato CN; Macedo A; Manadas B
Int J Mol Sci; 2022 May; 23(10):. PubMed ID: 35628270
[TBL] [Abstract][Full Text] [Related]
37. Characterizing the polygenic overlaps of bipolar disorder subtypes with schizophrenia and major depressive disorder.
Li Z; Li D; Chen X
J Affect Disord; 2022 Jul; 309():242-251. PubMed ID: 35487438
[TBL] [Abstract][Full Text] [Related]
38. Integrative analysis of epigenomics, transcriptomics, and proteomics to identify key targets and pathways of Weining granule for gastric cancer.
Liang MK; Liang XQ; Zhong J; Wei YT; Lian ZP; Huang ZK; Liang J
J Ethnopharmacol; 2021 Apr; 270():113787. PubMed ID: 33422657
[TBL] [Abstract][Full Text] [Related]
39. Associations between major psychiatric disorder polygenic risk scores and blood-based markers in UK biobank.
Sewell MDE; Jiménez-Sánchez L; Shen X; Edmondson-Stait AJ; Green C; Adams MJ; Rifai OM; McIntosh AM; Lyall DM; Whalley HC; Lawrie SM
Brain Behav Immun; 2021 Oct; 97():32-41. PubMed ID: 34107350
[TBL] [Abstract][Full Text] [Related]
40. Decreased AKT1/mTOR pathway mRNA expression in short-term bipolar disorder.
Machado-Vieira R; Zanetti MV; Teixeira AL; Uno M; Valiengo LL; Soeiro-de-Souza MG; Oba-Shinjo SM; de Sousa RT; Zarate CA; Gattaz WF; Marie SK
Eur Neuropsychopharmacol; 2015 Apr; 25(4):468-73. PubMed ID: 25726893
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
